Corcept Therapeutics

Corcept Therapeutics is a biopharmaceutical company focused on unlocking the potential of cortisol modulation to revolutionize the treatment of serious diseases. The company is dedicated to understanding and modulating cortisol activity at the glucocorticoid receptor to develop novel treatments for severe disorders. With more than 30 ongoing studies, Corcept is building a scientific foundation to deliver new approaches in fields such as endocrinology, oncology, metabolism, and neurology. The company aims to bring innovative therapies to patients by exploring new possibilities in cortisol modulation science.